Visitors and news

Cancer is the fourth leading cause of death in the Eastern Mediterranean Region with an estimated 676 500 new cases and 419 000 cancer deaths in 2018. The most common cancers in the region are respectively breast, colorectal, lung, liver and bladder. Authors of this editorial concluded that breast, colorectal and cervical cancer can be more effectively managed and prioritized through adoption of the suitable national early detection strategy when feasible.
Read the article

A new study led by researchers from the IARC and partners, published today in The Lancet Global Health, provides a comprehensive assessment of the global incidence and mortality patterns of cervical cancer.
Read the article and the IARC Press Release

Dr. Partha Basu attended this technical meeting within the framework of the iPAAC project organized by the Cancer Society of Finland to discuss the roadmap and deliverables to take a look into new developments and screening criteria and the new openings of cancer screening in Europe.

Get ready for the Giving Tuesday 2019 and support research on cancer prevention. Donate to increase the impact of International Agency for Research on Cancer global projects! Find out more about CanScreen5 project which improves the quality of cancer screening practices worldwide.
Read more about how to support IARC and learn more about opportunities of giving Tuesday 2019

Dr Zhihua Liu from the Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China visited the Screening group to discuss areas of potential collaboration.

As part of the CANelles project, Dr Patricia Villain from the Screening Group team organized this workshop to guide the development and implementation of shared decision making (SDM) online tools to help women make decisions in breast cancer screening. The participants include Dr Robert Smith (American Cancer Society, USA), Dr Raúl Murillo (Centro Javeriano de Oncología, Colombia), Dr Sonali Johnson (Union for International Cancer Control), and Dr Eleni Tolma (Kuwait University Health Sciences Center).

Dr. Partha Basu attended the meeting organized by WHO Regional Office for South-East Asia (SEARO).
More detail about Maternal, newborn, child and adolescent health

Dr Partha Basu conducted field visits and meetings in Pune, Barshi, Chennai, Kolkata and Delhi to discuss the implementation of the follow-up protocol of the Screening Group’s multicentre HPV vaccine study.

Dr Li Zhang, PhD in Peking Union Medical College, Beijing, China, has recently joined the Screening Group at IARC as a postdoctoral fellow. Li will be involved in the Cancer Screening in Five Continents (CanScreen5) project and will facilitate communication and data acquisition with the data provider network.

The Screening Group is delighted to present the early results of a new pilot study done in Lusaka, Zambia and published in the Lancet Oncology. This study compared three different treatments in women who were eligible for ablative therapy for cervical pre-cancer (crytherapy, LLETZ and thermal ablation). The results of the pilot study provide valuable evidence to inform the recently published WHO recommendation for using thermal ablation to treat cervical pre-cancers. Read the article, the commentary, the IARC News and the WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions.